Document Detail


Influence of exercise rehabilitation on myocardial perfusion and sympathetic heart innervation in ischaemic heart disease.
MedLine Citation:
PMID:  10774887     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Exercise rehabilitation improves the clinical status in ischaemic heart disease. The purpose of this study was to assess the influence of exercise rehabilitation on myocardial perfusion and sympathetic heart innervation. Sixteen patients with ischaemic heart disease and previous myocardial infarction were investigated by means of exercise/rest tetrofosmin and metaiodobenzylguanidine (MIBG) exercise/rest single-photon emission tomography (SPET) studies, before and 6 months after starting an exercise rehabilitation programme. Tomograms were divided into 15 segments, and these were grouped into five myocardial anatomical regions. Regional uptake of both tracers was quantified and expressed as a percentage of maximum peak activity. The percentage < or =55% was chosen to evaluate defect size, and the results were expressed as a percentage of left ventricular mass. Areas with perfused and denervated myocardium and areas with ischaemic myocardium were calculated. In addition, regions with <75% of peak activity in the exercise perfusion study at baseline were divided into two groups according to whether there was an increase in peak activity of >10% (representing reversible regional defects) or an increase of <10% (representing fixed regional defects) in the rest study. These percentages were compared with the percentages obtained in the innervation study, and with the percentages obtained in exercise/rest perfusion and innervation studies performed 6 months after starting rehabilitation. Myocardial perfusion defects were significantly smaller than myocardial innervation defects before and 6 months after starting exercise rehabilitation. The area of ischaemia 6 months after starting exercise rehabilitation was significantly smaller than that before rehabilitation (0.31%+/-1.4% vs 1.4%+/-1.6%, P<0.01). The size of innervation defects and the area of perfused and denervated myocardium did not show significant differences between the two studies performed before and 6 months after starting exercise rehabilitation. In reversible regional defects the percentage of peak activity was significantly increased 6 months after starting exercise rehabilitation in exercise and rest studies (P<0.001), while in fixed regional defects it was significantly increased only in exercise studies (P<0.001). There was no significant change in the regional MIBG percentages. We conclude that in ischaemic heart disease, exercise rehabilitation over a period of 6 months improves myocardial perfusion, but does not cause changes in sympathetic myocardial innervation.
Authors:
M Estorch; A Flotats; R Serra-Grima; C Mari; T Prat; J C Martín; L Bernà; A M Catafau; A Tembl; I Carrió
Related Documents :
22221437 - Impact of exercise-related respiratory symptoms in adults with asthma: exercise-induced...
17577127 - Vestibular rehabilitation outcomes in chronic vertiginous patients through computerized...
20588097 - The use of optokinetic stimulation in vestibular rehabilitation.
19251787 - Clinical relevance of constant power exercise duration changes in copd.
10880877 - Involvement of ca(2+) in antiarrhythmic effect of ischemic preconditioning in isolated ...
21377117 - Transpulmonary plasma catecholamines in acute high-altitude pulmonary hypertension.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of nuclear medicine     Volume:  27     ISSN:  0340-6997     ISO Abbreviation:  Eur J Nucl Med     Publication Date:  2000 Mar 
Date Detail:
Created Date:  2000-05-18     Completed Date:  2000-05-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7606882     Medline TA:  Eur J Nucl Med     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  333-9     Citation Subset:  IM    
Affiliation:
Department of Nuclear Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. mestorch@hsp.santpau.es
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3-Iodobenzylguanidine / diagnostic use
Blood Pressure
Coronary Circulation*
Coronary Disease / physiopathology,  radionuclide imaging,  rehabilitation*
Exercise Test
Exercise Therapy*
Heart / innervation*
Heart Rate
Humans
Iodine Radioisotopes / diagnostic use
Male
Middle Aged
Organophosphorus Compounds / diagnostic use
Organotechnetium Compounds / diagnostic use
Radiopharmaceuticals / diagnostic use
Sympathetic Nervous System / physiopathology*
Tomography, Emission-Computed, Single-Photon
Chemical
Reg. No./Substance:
0/Iodine Radioisotopes; 0/Organophosphorus Compounds; 0/Organotechnetium Compounds; 0/Radiopharmaceuticals; 0/technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane; 77679-27-7/3-Iodobenzylguanidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relation between exercise-induced ventricular arrhythmias and myocardial perfusion abnormalities in ...
Next Document:  Influence of drugs on myocardial iodine-123 metaiodobenzylguanidine uptake in rabbit myocardium.